| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/12/2012 | US20120010203 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments |
| 01/12/2012 | US20120010197 Protein kinase inhibitors |
| 01/12/2012 | US20120010188 Imidazopyridine Compounds |
| 01/12/2012 | US20120010174 Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
| 01/12/2012 | US20120010166 Stable iron oligosaccharide compound |
| 01/12/2012 | US20120010143 Adhesive hemostatic agent based on porcine atelocollagen and method for production thereof |
| 01/12/2012 | US20120010142 Natriuretic activities |
| 01/12/2012 | US20120010135 Spiro derivatives for the modulation of stearoyl-coa desaturase |
| 01/12/2012 | US20120009273 Kit of pharmaceutical formulations characterized by the presence of molecular oxygen |
| 01/12/2012 | US20120009268 Modified Virus Vectors and Methods of Making and Using the Same |
| 01/12/2012 | US20120009259 Formulation for co-therapy treatment of diabetes |
| 01/12/2012 | US20120009242 Blood coagulation inducing polymer hydrogel |
| 01/12/2012 | US20120009188 Optimized fc variants |
| 01/12/2012 | US20120009172 Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor |
| 01/12/2012 | US20120009161 Therapeutic retroviral vectors for gene therapy |
| 01/12/2012 | US20120006716 Humanized anti-il-6 antibodies |
| 01/12/2012 | CA2804595A1 Endothelial cell production by programming |
| 01/12/2012 | CA2804274A1 Factor ix polypeptides and methods of use thereof |
| 01/11/2012 | EP2404932A1 Polypeptides and antibacterial or antiseptic use of same |
| 01/11/2012 | EP2404920A1 Crystalline form of Rivaroxaban dihydrate |
| 01/11/2012 | EP2404906A1 Methods of synthesizing pharmaceutical salts of a factor XA inhibitor |
| 01/11/2012 | EP2404603A1 Novel trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds for the treatment of CSBP/p38 kinase mediated diseases |
| 01/11/2012 | EP2403521A1 Novel uses of fibrinogen |
| 01/11/2012 | EP2403498A2 Enhancing coagulation or reducing fibrinolysis |
| 01/11/2012 | EP1609798A9 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 01/11/2012 | EP1381377B1 A composition including a ginkgolide and apocynin which interferes with the arachidonic acid cascade |
| 01/11/2012 | EP1370288B1 Method for treating thrombocytopenia with monoclonal ivig |
| 01/11/2012 | EP0975672B1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 01/11/2012 | CN1997385B Annexin V for preventing atherothrombois and plaque rupture |
| 01/11/2012 | CN102317278A 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2 |
| 01/11/2012 | CN102316893A Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents |
| 01/11/2012 | CN102316873A Compounds and methods for enhancing erythropoiesis |
| 01/11/2012 | CN102311868A Method for extracting krill oil rich in phospholipids and neutral lipid without using solvent |
| 01/11/2012 | CN102311485A Polypeptide with neovascularization suppression effect and application thereof |
| 01/11/2012 | CN102309765A Long-acting anticoagulant polypeptide including immunoglobulin Fc segments as carriers and preparation method of same |
| 01/11/2012 | CN102309678A Natural product-based film coating agent capable of quickly stopping bleeding |
| 01/11/2012 | CN102309637A Yang restoring open fire moxibustion rod |
| 01/11/2012 | CN102309630A Processing method for toxicity reduction and efficacy enhancement of rhizoma alismatis |
| 01/11/2012 | CN102309610A Toxin expelling liquid for clearing human body toxins |
| 01/11/2012 | CN102309609A Traditional Chinese medicine pill for treating night sweats |
| 01/11/2012 | CN102309594A Traditional Chinese medicine prescription for treating heart palpitations |
| 01/11/2012 | CN102309574A Chinese medicinal pill for treating hematochezia |
| 01/11/2012 | CN102309572A Blood nourishing oral liquid and preparation method thereof |
| 01/11/2012 | CN102309539A Spina gleditsiae extract hydrogel patch and preparation method thereof |
| 01/11/2012 | CN102309533A Preparation method of total flavones of artemisia anomalas |
| 01/11/2012 | CN102309529A Method for microwave extraction of aescine in Chinese buckeye seeds |
| 01/11/2012 | CN102309518A Application of drug composition in preparation of drugs for treating anemia |
| 01/11/2012 | CN102309508A Application of drug composition in preparation of drugs for treating anemia |
| 01/11/2012 | CN102309497A Pharmaceutical composition for cardio cerebrovascular diseases |
| 01/11/2012 | CN102309496A Pharmaceutical composition for treating cardiovascular and cerebrovascular diseases |
| 01/11/2012 | CN102309494A Medicinal application of pristimerin as inflammatory cytokine inhibitor |
| 01/11/2012 | CN102309482A Clopidogrel hydrogensulfate composition and preparation method thereof |
| 01/11/2012 | CN102078511B Medicine for promoting leukopoiesis |
| 01/11/2012 | CN102078336B Traditional Chinese medicine composition with function of improving microcirculation and preparation method and application thereof |
| 01/11/2012 | CN102078300B Solid preparation of Torasemide liposome |
| 01/11/2012 | CN102058753B Medicament for replenishing qi to invigorate spleen and preparation method |
| 01/11/2012 | CN101919833B Application of aromatic compounds in preparing Caspase 3 inhibitor |
| 01/11/2012 | CN101829129B Veterinary compound gentamycin sulfate injection and preparation method thereof |
| 01/11/2012 | CN101810735B Method for extracting total flavone from ampelopsis grossedentata |
| 01/11/2012 | CN101773508B Stable Trifusal pharmaceutical composition |
| 01/11/2012 | CN101732678B Chinese medicinal powder for stopping bleeding, diminishing inflammation and promoting regeneration of mucosa |
| 01/11/2012 | CN101632509B Medicinal treatment shoe |
| 01/11/2012 | CN101485777B Method for producing medicament composition for tonifying blood |
| 01/11/2012 | CN101444559B Granular formulation with heat-clearing and detoxicating, promotion of diuresis and tonglin function and preparation method and detection method |
| 01/11/2012 | CN101293053B Detection method for E-jiao hematinic ointment |
| 01/11/2012 | CN101267832B Platelet aggregation inhibitor and health food effective in inhibiting platelet aggregation |
| 01/11/2012 | CN101254275B Chinese medicine for curing aplastic anemia |
| 01/11/2012 | CN101190281B Prune tree extract and preparation method and application thereof |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8093251 Nitrogen-containing heterocyclic compounds and thrombopoietin receptor activators |
| 01/10/2012 | US8093042 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 01/10/2012 | CA2455559C Methods to mobilize progenitor/stem cells |
| 01/10/2012 | CA2436665C Nucleic acid derivatives |
| 01/10/2012 | CA2400295C Modified factor viii |
| 01/10/2012 | CA2382105C Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 01/05/2012 | WO2012003477A2 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
| 01/05/2012 | WO2012002577A1 Novel nicotinamide derivatives or salts thereof |
| 01/05/2012 | WO2012002502A1 Dihydropyrimidinone derivative and pharmaceutical use thereof |
| 01/05/2012 | WO2012002464A1 ω3 FATTY ACID COMPOUND PREPARATION |
| 01/05/2012 | WO2012001087A1 Antibodies that are capable of specifically binding tissue factor pathway inhibitor |
| 01/05/2012 | WO2012000899A1 Semuloparin for use as an antithrombotic treatment in orthopaedic surgery with improved benefit-risk profile |
| 01/05/2012 | WO2012000212A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | WO2012000187A1 Fusion protein of g-csf variant, preparation method and use thereof |
| 01/05/2012 | US20120004720 G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| 01/05/2012 | US20120004636 Hemostatic fibrous material |
| 01/05/2012 | US20120004312 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/05/2012 | US20120004311 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic b-cell lymphoma/leukemia-2 (bcl-2) |
| 01/05/2012 | US20120004283 Novel shrna gene therapy for treatment of ischemic heart disease |
| 01/05/2012 | US20120004263 Compounds for the treatment of pathologies associated with aging and degenerative disorders |
| 01/05/2012 | US20120004261 Mif modulators |
| 01/05/2012 | US20120004256 Parenteral formulation of clopidogrel |
| 01/05/2012 | US20120004248 Methods of using a methylxanthine compound |
| 01/05/2012 | US20120004228 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004216 Modulators of atp-binding cassette transporters |
| 01/05/2012 | US20120004197 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient |
| 01/05/2012 | US20120004186 Platelet aggregation inhibitor composition |
| 01/05/2012 | US20120004176 Liquid Composition of Factor VII Polypeptides |
| 01/05/2012 | US20120004174 Gh secretagogues and uses thereof |
| 01/05/2012 | US20120004164 Organic compounds |